NYSE and ASX-listed Resmed, a US-based sleep health technology company, has completed its acquisition of Noctrix Health, a US-based medical device company developing clinically validated wearable therapeutics for chronic neurological disorders, from Angelini Ventures in a transaction valued at US$340m.
The acquisition expands Resmed’s clinical sleep health portfolio into the...
US-based Signant Health, an evidence generation company, has acquired Ametris (formerly ActiGraph), a global digital health solutions provider, from Archimed.
Signant Health was formed in 2018 by the merger of CRF Health and Bracket to provide life science companies with patient-centric technology solutions that advance clinical research and transform the patient experience. The company’s integrated suite of applications combine advanced analytics and therapeutic area-specific scientific consulting, and are trusted by pharmaceutical companies of all sizes, including all of the top 20 pharmas, as well as CROs, biotechs, and academic institutions on...